Will AbbVie's new psoriasis drug Skyrizi (approved in Japan) receive U.S. Food and Drug Administration approval by 30 June 2019?
Started
Apr 09, 2019 05:47PM UTC
Closed Apr 23, 2019 07:45PM UTC
Closed Apr 23, 2019 07:45PM UTC
Resolution Notes
Received FDA approval by April 23, 2019. https://news.abbvie.com/news/press-releases/abbvie-expands-immunology-portfolio-in-us-with-fda-approval-skyrizi-risankizumab-rzaa-for-moderate-to-severe-plaque-psoriasis.htm
| Possible Answer | Correct? | Final Crowd Forecast |
|---|---|---|
| Yes | 73% |
Crowd Forecast Profile
| Participation Level | |
|---|---|
| Number of Forecasters | 2 |
| Average for questions older than 6 months: 11 | |
| Number of Forecasts | 2 |
| Average for questions older than 6 months: 48 | |
| Accuracy | |
|---|---|
| There are not enough forecasters in this question to generate an accuracy profile. |
